A phase I study of the fully human, fragment crystallizable-engineered, anti-CD-33 monoclonal antibody BI 836858 in patients with previously-treated acute myeloid leukemia

Haematologica. 2021 Dec 2. doi: 10.3324/haematol.2020.274118. Online ahead of print.ABSTRACTNot available.PMID:34854276 | DOI:10.3324/haematol.2020.274118

Source: Haematologica - December 2, 2021 Category: Hematology Authors: Sumithira Vasu Jessica K Altman Geoffrey L Uy Martin S Tallman Ivana Gojo Gerard Lozanski Ute Burkard Annika Osswald Pamela James Bj örn Rüter William Blum Source Type: research